SOHONOS 2.5 mg/1 (Palovarotene CAPSULE) 2.5 mg/1

SOHONOS 2.5 mg capsules contain palovarotene, a medication used for specific medical conditions. Learn about its uses, effects, and precautions here.

Strength

2.5 mg/1

Pack Size

1 BLISTER PACK in 1 CARTON (15054-0025-1) / 14 CAPSULE in 1 BLISTER PACK

Manufacturer / TM Owner

Ipsen Biopharmaceuticals, Inc.

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

SOHONOS 2.5 mg capsules are primarily used to manage certain medical conditions related to excessive bone growth. Palovarotene, the active ingredient, is often prescribed for conditions where controlling bone formation is necessary. Patients may wonder, 'What is palovarotene used for?' and the answer typically involves its role in regulating bone metabolism.

Side Effects

Common effects of SOHONOS 2.5 mg capsules may include mild gastrointestinal discomfort or changes in appetite. Some users might experience dry skin or mucous membranes. These effects can vary widely among individuals and are not exhaustive.

Precautions & Warnings

SOHONOS 2.5 mg capsules should be handled with care, stored as directed, and kept out of reach of children. It's important to follow the guidance of a healthcare provider regarding administration and monitoring. Always inform your healthcare provider about any pre-existing conditions or allergies.

Avoid Interactions

SOHONOS 2.5 mg capsules may interact with certain medications, including those that affect liver enzymes. Alcohol and other substances that impact liver function should be discussed with a healthcare provider. Always disclose all current medications to avoid potential interactions.

Frequently Asked Questions

SOHONOS 2.5 mg capsules are used to manage conditions related to excessive bone growth, typically involving the regulation of bone metabolism.

SOHONOS 2.5 mg capsules should be stored at room temperature, away from moisture and heat, and kept out of reach of children.

Common side effects may include mild gastrointestinal discomfort, changes in appetite, and dry skin or mucous membranes.

Potential interactions with other medications should be discussed with a healthcare provider, especially those that affect liver enzymes.

SOHONOS 2.5 mg capsules may not be suitable for everyone, particularly those with certain pre-existing conditions or allergies.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.